|
Market Closed -
Australian S.E.
10:40:19 21/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 196.08 AUD | -0.11% |
|
+6.22% | +13.57% |
| 11:16am | Australia's CSL names GSK exec Deborah Waterhouse as next CEO | RE |
| 20/10 | BHP and National Australia Bank drag Aussie shares lower | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 6.58TCr | |||||
| 1,14400Cr | |||||
| 63TCr | |||||
| 51TCr | |||||
| 38TCr | |||||
| 37TCr |
- Stock Market
- Stocks
- CSL Stock
- Charts CSL Limited
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
